Healthcare provider profile · identity verified

Rajesh Kumar Nallapati, MD

Internal Medicine · DOVER, PA · NPI 1104855758

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	633	172
Metoprolol Succinate	Metoprolol Succinate	410	105
Amlodipine Besylate	Amlodipine Besylate	387	109
Levothyroxine Sodium	Levothyroxine Sodium	362	97
Losartan Potassium	Losartan Potassium	335	93
Pantoprazole Sodium	Pantoprazole Sodium	329	94
Rosuvastatin Calcium	Rosuvastatin Calcium	324	91
Gabapentin	Gabapentin	295	68
Lisinopril	Lisinopril	270	75
Metformin Hcl	Metformin Hcl	241	61
Eliquis	Apixaban	235	44
Hydrochlorothiazide	Hydrochlorothiazide	227	68
Albuterol Sulfate Hfa	Albuterol Sulfate	217	69
Furosemide	Furosemide	212	57
Tamsulosin Hcl	Tamsulosin Hcl	190	47
Pravastatin Sodium	Pravastatin Sodium	188	54
Sertraline Hcl	Sertraline Hcl	181	48
Simvastatin	Simvastatin	179	52
Omeprazole	Omeprazole	173	47
Glipizide Er	Glipizide	171	46
Alendronate Sodium	Alendronate Sodium	165	40
Jardiance	Empagliflozin	158	27
Tramadol Hcl	Tramadol Hcl	155	39
Pregabalin	Pregabalin	146	35
Fluticasone Propionate	Fluticasone Propionate	133	56
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	133	38
Allopurinol	Allopurinol	120	29
Prednisone	Prednisone	117	73
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	113	33
Carvedilol	Carvedilol	110	29
Trulicity	Dulaglutide	106	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	101	26
Metformin Hcl Er	Metformin Hcl	100	30
Clopidogrel	Clopidogrel Bisulfate	94	27
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	91	17
Escitalopram Oxalate	Escitalopram Oxalate	89	25
Azithromycin	Azithromycin	86	69
Amoxicillin	Amoxicillin	85	54
Finasteride	Finasteride	83	19
Oxycodone Hcl	Oxycodone Hcl	79	17
Metoprolol Tartrate	Metoprolol Tartrate	74	25
Zolpidem Tartrate	Zolpidem Tartrate	72	17
Famotidine	Famotidine	71	21
Citalopram Hbr	Citalopram Hydrobromide	70	17
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	66	suppressed
Lorazepam	Lorazepam	66	27
Venlafaxine Hcl Er	Venlafaxine Hcl	65	17
Quetiapine Fumarate	Quetiapine Fumarate	64	12
Repaglinide	Repaglinide	63	22
Duloxetine Hcl	Duloxetine Hcl	62	21
Meloxicam	Meloxicam	60	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	16
Tizanidine Hcl	Tizanidine Hcl	58	29
Fluoxetine Hcl	Fluoxetine Hcl	56	16
Synthroid	Levothyroxine Sodium	53	16
Donepezil Hcl	Donepezil Hcl	52	11
Clonazepam	Clonazepam	51	12
Ezetimibe	Ezetimibe	51	12
Hydralazine Hcl	Hydralazine Hcl	50	12
Montelukast Sodium	Montelukast Sodium	49	16
Ondansetron Odt	Ondansetron	49	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	47	32
Ventolin Hfa	Albuterol Sulfate	46	12
Calcitriol	Calcitriol	45	suppressed
Propranolol Hcl	Propranolol Hcl	44	15
Valsartan	Valsartan	44	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Potassium Chloride	Potassium Chloride	42	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	39	11
Dutasteride	Dutasteride	39	11
Alprazolam	Alprazolam	38	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	35
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Methenamine Hippurate	Methenamine Hippurate	38	suppressed
Hydrocortisone	Hydrocortisone	37	19
Mirtazapine	Mirtazapine	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	11
Spironolactone	Spironolactone	36	11
Glimepiride	Glimepiride	35	15
Incruse Ellipta	Umeclidinium Bromide	33	suppressed
Linzess	Linaclotide	33	suppressed
Naproxen	Naproxen	33	12
Fentanyl	Fentanyl	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	28
Nortriptyline Hcl	Nortriptyline Hcl	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Xarelto	Rivaroxaban	31	11
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	suppressed
Cephalexin	Cephalexin	27	15
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Bydureon Bcise	Exenatide Microspheres	26	suppressed
Trazodone Hcl	Trazodone Hcl	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	25	suppressed
Dexmethylphenidate Hcl Er	Dexmethylphenidate Hcl	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Bupropion Xl	Bupropion Hcl	24	12
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Varenicline Tartrate	Varenicline Tartrate	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	11
Ibuprofen	Ibuprofen	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Nystatin	Nystatin	23	14
Atenolol	Atenolol	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Nitroglycerin	Nitroglycerin	21	17
Ozempic	Semaglutide	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Klor-Con M20	Potassium Chloride	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	13
Baclofen	Baclofen	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Methylprednisolone	Methylprednisolone	18	17
Nifedipine Er	Nifedipine	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	16
Ketoconazole	Ketoconazole	17	11
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Topiramate	Topiramate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Digoxin	Digoxin	16	suppressed
Estradiol	Estradiol	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Oxycontin	Oxycodone Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	13
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	13	suppressed
Glipizide	Glipizide	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Serevent Diskus	Salmeterol Xinafoate	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Delstrigo	Doravirine/Lamivu/Tenofov Diso	12	suppressed
Flovent Hfa	Fluticasone Propionate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error